Novogene released its 2026 interim report, with total operating revenue of 1.114 billion yuan and net profit attributable to the parent company of 63.12 million yuan, a decrease of 19.82% compared with the same period last year. Net cash flow from operating activities was negative 32.38 million yuan, ranking 26th among disclosed peer companies. The company's asset-liability ratio was 30.39%, gross margin was 41.86%, return on equity was 2.35%, and diluted earnings per share was 0.16 yuan, down 15.79% from the same period last year. The number of shareholders was 9,114, and the top ten shareholders held 71.87% of the total share capital.
Novogene Co. Ltd.Net profit down 19.82% year-on-year, operating cash flow negative.
